Pharmacogenetics in Primary Care Psychotropics
试验速览
- 阶段
- 3 期
- 入组人数
- 130
- 主要终点
- Patient oriented outcome1- Clinical Improvement
研究概览
简要总结
Pragmatic trial of pharmacogenetic testing at the time of prescription for a selective serotonin reuptake inhibitor, tricyclic antidepressant or atypical antipsychotic. Does real time intervention improve patient outcomes?
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Prescribed a drug of interest for the first time
排除标准
- •Previous pharmacogenetic testing available
结局指标
主要结局
Patient oriented outcome1- Clinical Improvement
时间窗: 6 months
Clinically significant improvement as noted by physician (Subjective and PHQ-9)
Patient oriented outcome2- Adverse effects
时间窗: 6 months
Number of patients with specific, common side effects (from medical chart)
Patient oriented outcome3- Time to Improvement
时间窗: Up to 6 months
Days to clinical improvement (from medical chart)
Patient oriented outcome5- Visits
时间窗: 6 months
Total number of visits to clinic with medication titration required (from medical chart)
次要结局
未报告次要终点
